0 Commentarii
0 Distribuiri
96 Views
0 previzualizare
Căutare
Descoperă oameni noi, creează noi conexiuni și faceti-va noi prieteni
-
Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
-
How Do Regulatory Fast-Track Approvals Influence the Oncology Drugs Market?Oncology Drugs Market: Growth, Trends, Key Companies & Future Outlook (2025–2033) The Oncology Drugs Market is on a strong upward trajectory, driven by innovations in cancer treatment, expanding patient populations, and ongoing advancements in biotechnology and pharmaceuticals. With an estimated market valuation of USD 253.6 billion in 2025, this sector is expected to...0 Commentarii 0 Distribuiri 610 Views 0 previzualizare
-
Newly Released: Chemotherapy Drugs Market Growth and Oncology Treatment Trends" Exactitude Consultancy That Adds Flavour To Your Success" Exactitude Consultancy has just rolled out its latest market research report titled "Chemotherapy Drugs Market. Market Size, Share, Growth Outlook & Industry Analysis Report: By Product Type (Antimetabolites, Alkylating Agents, Mitotic Inhibitors, Topoisomerase Inhibitors), By Application (Breast Cancer, Lung Cancer,...0 Commentarii 0 Distribuiri 102 Views 0 previzualizare
-
Oral HER Pathway Targeted Drugs Market Advances with Precision Oncology Developments"In-Depth Study on Executive Summary Oral HER Pathway Targeted Drugs Market Size and Share CAGR Value The global oral HER pathway targeted drugs market size was valued at USD 6.24 billion in 2025 and is expected to reach USD 15.01 billion by 2033, at a CAGR of 11.60% during the forecast period The Oral HER Pathway Targeted Drugs Market report contains...0 Commentarii 0 Distribuiri 189 Views 0 previzualizare
-
Spindle Cell Sarcoma Drugs Market – Targeted Oncology Therapies & Rare Cancer Treatment Progress"Executive Summary Spindle Cell Sarcoma Drugs Market Opportunities by Size and Share CAGR Value Data Bridge Market Research analyses that the global spindle cell sarcoma drugs market is expected which was USD 27030.00 million 2022 is expected to reach USD 43081.71 million 2030 to undergo a CAGR of 6.00% during the forecast period 2023-2030. The leading Spindle Cell Sarcoma Drugs...0 Commentarii 0 Distribuiri 1K Views 0 previzualizare
-
What Role Does AI Play in the Oncology Drugs Market Development?Oncology Drugs Market Overview: Trends, Growth, and Forecast 2025-2033 The oncology drugs market is one of the most dynamic and critical segments in the global pharmaceutical industry. As cancer remains a leading cause of mortality worldwide, the demand for innovative and effective oncology treatments continues to surge. According to recent market analysis, the oncology drugs...0 Commentarii 0 Distribuiri 1K Views 0 previzualizare
-
Which Companies Dominate the Oncology Drugs Market in 2025?Oncology Drugs Market Overview 2025–2033: Size, Trends, Key Companies, Segments, and Growth Drivers The Oncology Drugs Market is one of the fastest-growing segments in the global pharmaceutical industry. According to the latest industry analysis, the global oncology drugs market size is projected to grow from USD 253.6 billion in 2025 to an impressive USD 580.2...0 Commentarii 0 Distribuiri 851 Views 0 previzualizare
-
Which Segment is Growing Fastest in the Oncology Drugs Market?Oncology Drugs Market Overview 2025–2033: Size, Growth Drivers, Key Segments, and Leading Companies The global Oncology Drugs Market is on the verge of remarkable expansion. According to the latest industry analysis, the oncology drugs market size is projected to grow from approximately USD 253.6 billion in 2025 to an impressive USD 580.2 billion by 2033,...0 Commentarii 0 Distribuiri 906 Views 0 previzualizare
-
Anti-Cancer Drug Market Companies: Growth, Share, Value, Size, and Insights"Executive Summary Anti-Cancer Drug Market: Share, Size & Strategic Insights Data Bridge Market Research analyses that the global anti-cancer drug market which was USD 1,20,000.00 million in 2022, would rocket up to USD 2,97,000.00 million by 2030, and is expected to undergo a CAGR of 12.0% during the forecast period. The Anti-Cancer Drug report provides CAGR values along with its...0 Commentarii 0 Distribuiri 4K Views 0 previzualizare
-
Are HER2 Inhibitors Transforming Targeted Therapy in Oncology Treatment?Executive Summary HER2 Inhibitors Market: Share, Size & Strategic Insights CAGR Value The global HER2 inhibitors market size was valued at USD 11.05 billion in 2025 and is expected to reach USD 22.02 billion by 2033, at a CAGR of 9.00% during the forecast period HER2 Inhibitors Market research report works best for the systematic gathering,...0 Commentarii 0 Distribuiri 465 Views 0 previzualizare
-
Are Immune-Modulating Biologics Redefining the Future of Cancer Immunotherapy?Executive Summary Immune-Modulating Oncology Biologic Drugs Market Size and Share: Global Industry Snapshot CAGR Value The global immune-modulating oncology biologic drugs market size was valued at USD 10.10 billion in 2025 and is expected to reach USD 28.54 billion by 2033, at a CAGR of13.87% during the forecast period The research and analysis...0 Commentarii 0 Distribuiri 381 Views 0 previzualizare
-
Brigatinib API Market Growing at 8.1% CAGR Through 2034 GloballyAccording to a new report from Intel Market Research, the global Brigatinib API market was valued at USD 42.5 million in 2025 and is projected to reach USD 89.7 million by 2034, growing at a robust CAGR of 8.1% during the forecast period (2026–2034). This growth is propelled by the increasing global incidence of non-small cell lung cancer, particularly ALK-positive cases among...0 Commentarii 0 Distribuiri 89 Views 0 previzualizare
-
Can Advanced Therapies Effectively Combat the Rising Cases of Actinic Keratosis?Market Trends Shaping Executive Summary Actinic Keratosis Treatment Market Size and Share CAGR Value The global actinic keratosis treatment market size was valued at USD 3.36 billion in 2025 and is expected to reach USD 9.02 billion by 2033, at a CAGR of 13.14% during the forecast period A complete discussion about numerous market-related topics...0 Commentarii 0 Distribuiri 321 Views 0 previzualizare
-
Can Targeting Endocrine Resistance Unlock New Breakthroughs in Cancer Treatment?Executive Summary Endocrine Resistance–Targeting Drug Market Size and Share Analysis Report CAGR Value The global endocrine resistance–targeting drug market size was valued at USD 2.96 billion in 2025 and is expected to reach USD 8.50 billion by 2033, at a CAGR of 14.10% during the forecast period This Endocrine...0 Commentarii 0 Distribuiri 578 Views 0 previzualizare
-
Global Selpercatinib Capsules Market Growing at 7.8% CAGR Through 2034According to a new report from Intel Market Research, the global Selpercatinib Capsules market was valued at USD 420 million in 2025 and is projected to reach USD 820 million by 2034, growing at a CAGR of 7.8% during the forecast period (2026–2034). This growth is propelled by the increasing prevalence of RET-altered cancers, growing adoption of biomarker-driven therapies, and...0 Commentarii 0 Distribuiri 118 Views 0 previzualizare
-
Is Synthetic Lethality the Future Breakthrough in Targeted Cancer Therapy?Executive Summary Synthetic Lethality Drug Market Size and Share Analysis Report CAGR Value The global Synthetic Lethality Drug market size was valued at USD 1.93 billion in 2025 and is expected to reach USD 8.07 billion by 2033, at a CAGR of 19.60% during the forecast period This Synthetic Lethality Drug Market research report guides the...0 Commentarii 0 Distribuiri 351 Views 0 previzualizare
Sponsorizeaza Paginile
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Portuguese (Brazil)
Greek